课题基金 / 基金详情

Understanding the role of PCNA in DNA mismatch repair subpathways

Understanding the role of PCNA in DNA mismatch repair subpathways
了解 PCNA 在 DNA 错配修复子通路中的作用
批准号:
8698171
负责人:
Eva Marie Goellner
金额:
$5.33万
依托单位国家:
美国
项目类别:
财政年份:
2013
资助国家:
美国
项目状态:
已结题
起止时间:
2013-07-01 至 2015-06-30

项目摘要

项目成果

Eva Marie Goellner的其他基金

相似基金

相关文献

中文摘要
翻译
描述(由申请人提供):DNA损伤修复途径对于维持基因组稳定性和防止原癌基因或肿瘤抑制基因的突变至关重要,这些突变随后驱动癌症的发展。考虑到许多化疗药物通过破坏DNA发挥作用,了解DNA修复途径也至关重要。通过这种方式,DNA修复途径不仅影响癌症易感性,而且影响癌症化疗的疗效。DNA错配修复(MMR)途径的功能是修复在正常DNA复制过程中发生的碱基对错配和小的插入/删除错配。MMR的缺陷导致突变率增加,并导致癌症易感综合征,如Lynch综合征和散发性肿瘤。与定义明确的大肠杆菌MMR途径不同,真核MMR中错配识别下游修复的确切机制尚不清楚。我们最近在葡萄球菌中的实验发现了至少两种MMR亚通路的存在:1)与DNA复制偶联的外切酶1 (Exo1)独立通路和2)外切酶1依赖通路。对于这些MMR亚通路的具体机制或它们对人类癌症发展或化疗反应的影响知之甚少。增殖细胞核抗原(PCNA)是MMR通路的一个组成部分,尽管其机制作用尚不完全清楚。PCNA是错配切除后DNA合成所必需的,并在上游修复步骤中发挥多种作用,可能决定MMR亚通路的功能。该项目将在编码PCNA的POL30中产生一系列功能分离突变,这些突变通过靶向遗传筛选导致MMR的exo1独立或exo1依赖亚通路功能障碍。这些突变将通过功能性生化和细胞生物学分析来表征,以剖析PCNA在每个亚通路中的机制作用,并阐明错配识别下游真核MMR的鲜为人知的细节。这一机制数据将用于指导未来关于PCNA突变和MMR亚通路缺陷如何影响人类肿瘤形成和化疗耐药性的实验。
英文摘要
DESCRIPTION (provided by applicant): DNA damage repair pathways are critical for maintaining genome stability and preventing mutations in proto- oncogenes or tumor suppressor genes that then drive the development of cancer. Understanding DNA repair pathways is also critical given that many chemotherapeutic agents function by damaging DNA. In this way DNA repair pathways not only influence cancer susceptibility but also affect the efficacy of cancer chemotherapy. The DNA mismatch repair (MMR) pathway functions to repair base pair mismatches and small insertion/deletion mispairs that occur during normal DNA replication. Defects in MMR result in increased mutation rates and lead to cancer predisposition syndromes, such as Lynch syndrome, and sporadic tumors. Unlike the well-defined E. coli MMR pathway, the exact mechanisms of repair downstream of mispair recognition in eukaryotic MMR are still unclear. Our recent experiments in S. cerevisiae have uncovered the existence of at least two MMR sub pathways: 1) an Exonuclease1 (Exo1)-independent pathway that appears to be coupled to DNA replication and 2) an Exo1-dependent pathway. Little is known about the specific mechanisms of these MMR subpathways or their impact on human cancer development or response to chemotherapy. PCNA (Proliferating Cell Nuclear Antigen) is an integral part of the MMR pathway, although its mechanistic roles are not completely understood. PCNA is required for DNA synthesis after excision of the mispair, and plays multiple roles in upstream repair steps that potentially dictate MMR sub pathway function. This project will generate a collection of separation-of-function mutations in POL30, which encodes PCNA, that cause dysfunction in either the Exo1-independent or Exo1-dependent sub pathways of MMR by using targeted genetic screening. These mutations will be characterized with functional biochemical and cell biological assays to dissect the mechanistic roles of PCNA within each sub pathway and to illuminate the poorly understood details of eukaryotic MMR downstream of mispair recognition. This mechanistic data will be used to guide future experiments into how PCNA mutations and MMR sub pathway defects influence human tumor formation and chemotherapy resistance.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Mechanisms of mismatch repair mediated cell death after alkylating agent exposure
  • 批准号:
    9761615
  • 项目类别:
  • 资助金额:
    $24.9万
  • 财政年份:
    2018
  • 负责人:
    Eva Marie Goellner
  • 依托单位:
Mechanisms of mismatch repair mediated cell death after alkylating agent exposure
Understanding the role of PCNA in DNA mismatch repair subpathways
海外基金